B-Cure Laser (Founded 2009, over 250K devices sold globally) has developed a low-level laser therapy treatment for an effective treatment of acute and chronic pain, orthopedic conditions, sports injuries, and wounds. It is safe, clinically proven, and CE-approved. Furthermore, it is portable and rechargeable, so it can be used both at home and in the clinic.



Our Representatives

More Schlosser

BDM, B-Cure Laser

BDM

B-Cure Laser

About the company : B-Cure Laser was Founded in 2009. More than 250K devices were sold globally. Six Double blind clinical trials were made on the product . The product is based on a lo...

Company's Solutions

KEY BENEFITS:

ADVANCED TECHNOLOGY: B-Cure Laser is based on LLLT (Low Level Laser Therapy) technology, that may treat the pain and its source effectively.

CLINICALLY PROVEN AND SAFE: B-Cure Laser’s efficacy and safety was proven in 5 double-blind studies, all of which confirmed its clinical value.

USER FRIENDLY: Thanks to its compact, lightweight shape, you can treat yourselves anytime and anywhere!

Patent Registered : The innovation, we have developed a unique electro-optic mechanism, which allows for the first time to emit 5 Joules per minute over a wide area of 4.5 sq.cm, applying a fully coherent beam. It represents a new category in Soft Laser technology-the only of its kind.

GOOD ENERGIES is far more than our name. It is our greeting and motto, and ingrained in our company vision and spirit.

Prominent Case Study

B-Cure Laser is a clinically proven medical device, for treating pain and its source effectively, at clinics and at home.
We have already conducted 5 clinical trials, each with an active group, and a placebo control group. All the results were strong and statistically significant.

Please find attached the following clinical trials and materials:

1.The clinical trial from Sapienza University, Rome, Italy, was published on April 2019 in Cranio Journal – PubMed.
The double blind clinical trial , involving 90 patients, has shown a significant pain reduction in the active group vs the B-Cure Placebo Laser . Significance - p<0.01

2.B-Cure Laser – The “at-home LLLT" in Temporomandibular disorders pain control, University of Pharma, Italy. Published in the “Laser therapy”, March 2015
A 50% decrease in pain level within two weeks compared to 8% in the control group. Significance - p<0.0001.

3.B-Cure Laser – LLLT prevents complications post laminectomy, Beneficencia of Sao Paulo Hospital, Brazil. Published in: American Society for Laser Medicine and Surgery.
The results showed a decrease of temperature, drainage output, pain relief and accelerated healing in laser group. Significance - p<0.001 (pain).

4.The statistical report of the clinical trial on Diabetic Foot Ulcer, which was presented in Dec 2007 in the IOA conference in Tel-Aviv.
12 weeks of daily B-Cure Laser Pro treatments have significantly decreased wound size in patients with diabetic foot ulcers compared to sham irradiated controls. Significance - p=0.01.
70% of the active patients but only 11% of the sham patients had >90% wound closure by the end of the study. Significance - p=0.019.

5.A systematic literature review published in Photomedicine and Laser Surgery, supports the outstanding efficacy of B-Cure Laser vs. all medical photomedicine devices for home use worldwide, for the treatment of pain and wound healing.
B-Cure Laser was cited in 4 out of 14 studies which support the claim that Phototherapy is effective for the treatment of Pain and Wounds !
29% of the patients in the entire literature review studies received the B-Cure Laser therapy treatment.

6.Supportive care of cancer patients with a self- applied photo biomodulation device-B-Cure Laser: a case series, published on Jan 2021,about the treatment of Oral Mucositis-wounds which develop post oncology treatment.